In patient-derived samples, NLRP3 was overexpressed and highly activated in AML bone marrow leukemia cells, and this correlated with poor prognosis, and the activation of NLRP3 in AML cells promoted leukemia cell proliferation, inhibited apoptosis, and increased resistance to chemotherapy [19]. This evidence concerns the gene NLRP3 and acute myeloid leukemia.